- Report
- May 2025
- 188 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 188 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 191 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 180 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 197 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 191 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- November 2024
- 100 Pages
Global
From €2188EUR$2,490USD£1,887GBP
- Report
- May 2025
- 193 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
From €4305EUR$4,900USD£3,714GBP
- Report
- April 2025
- 175 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- April 2025
- 175 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- April 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- March 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- February 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- February 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- February 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- February 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- February 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- February 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- April 2025
- 250 Pages
Global
From €3945EUR$4,490USD£3,403GBP

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more